CalciMedica
CalciMedica
| Product | Rating | Most Used By | Product Summary | Starting Price |
|---|---|---|---|---|
 CalciMedica | N/A | CalciMedica is a privately held, clinical stage biotechnology company with a platform focused on CRAC channel drug discovery and development for the treatment of acute and severe inflammatory diseases. The Company was founded in 2007 by Ken Stauderman, CalciMedica’s Chief Scientific Officer, and colleagues at Torrey Pines Therapeutics in San Diego and Harvard’s Center for Blood Research in Cambridge, MA. Dr. Stauderman’s work includes the discovery of the role of STIM1, which works in… | N/A |
| CalciMedica | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Editions & Modules | No answers on this topic | ||||||||||
| Offerings |
| ||||||||||
| Entry-level Setup Fee | No setup fee | ||||||||||
| Additional Details | — | ||||||||||
| More Pricing Information | |||||||||||
| CalciMedica | |
|---|---|
| ScreenShots |